.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Pyrroloquinoline quinone (PQQ) is currently gaining significant attention in the field of PQQ anticancer drug design due to its unique redox properties. This quinone molecule acts as a vital cofactor for various enzymes within human cells. Consequently, it plays a central role in mitochondrial biogenesis and overall cellular health. While research traditionally focused on its role as a dietary supplement, scientists now recognize its potential as a therapeutic scaffold for oncology. Preclinical evidence suggests that PQQ can selectively target cancer cells while preserving healthy tissue.
Recent studies demonstrate that PQQ influences multiple molecular pathways. For example, it induces apoptosis in specific cancer cell lines, such as colorectal adenocarcinoma. Furthermore, PQQ modulates the tumor microenvironment by reducing oxidative stress and chronic inflammation. Researchers believe these chemical scaffolds offer a versatile platform for creating more targeted therapies. However, most current knowledge stems from animal models. Therefore, the transition to human clinical trials remains the next critical step for validating these laboratory findings.
Advancing PQQ into oncology requires a multifaceted approach. Future initiatives must involve testing in diverse animal tumor models to assess real-world efficacy. Moreover, analyzing synergistic effects with existing chemotherapeutic agents could improve patient outcomes. Improving drug formulations will also be necessary to boost absorption and bioavailability. Finally, discovering reliable biomarkers will help clinicians select the most suitable patients for PQQ-based interventions in the future.
PQQ induces apoptosis in cancer cells and modulates mitochondrial function. It also acts as a potent antioxidant, protecting healthy cells from oxidative damage during therapy.
No, PQQ is currently primarily available as a dietary supplement. While preclinical data for PQQ anticancer drug design is promising, human oncology trials are still in early stages.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sen S et al. Pyrroloquinoline quinone scaffolds: centrality in anticancer drug design. Future Med Chem. 2026 Apr 13. doi: 10.1080/17568919.2026.2658006. PMID: 41969172.
Flores-Encarnacion M et al. The Effect of Pyrroloquinoline Quinone (PQQ) on Viability of Human Colorectal Adenocarcinoma HT-29 Cell Line. Int J Res Stud Biosci. 2017;5(10):18-24.
Jonscher KR et al. Pyrroloquinoline-quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention. Biomolecules. 2021;11(10):1441.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of Pyrroloquinoline quinone (PQQ) as a redox-active molecule with promising potential in anticancer drug design and oncology research....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
